"Glioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Descriptor ID |
D005910
|
| MeSH Number(s) |
C04.557.465.625.600.380 C04.557.470.670.380 C04.557.580.625.600.380
|
| Concept/Terms |
Glioma- Glioma
- Gliomas
- Glial Cell Tumors
- Glial Cell Tumor
- Tumor, Glial Cell
- Tumors, Glial Cell
Mixed Glioma- Mixed Glioma
- Glioma, Mixed
- Gliomas, Mixed
- Mixed Gliomas
Malignant Glioma- Malignant Glioma
- Glioma, Malignant
- Gliomas, Malignant
- Malignant Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Glioma".
Below are MeSH descriptors whose meaning is more specific than "Glioma".
This graph shows the total number of publications written about "Glioma" by people in this website by year, and whether "Glioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 7 | 1 | 8 |
| 1995 | 8 | 2 | 10 |
| 1996 | 16 | 3 | 19 |
| 1997 | 9 | 4 | 13 |
| 1998 | 17 | 1 | 18 |
| 1999 | 12 | 8 | 20 |
| 2000 | 14 | 4 | 18 |
| 2001 | 16 | 2 | 18 |
| 2002 | 16 | 6 | 22 |
| 2003 | 21 | 5 | 26 |
| 2004 | 18 | 1 | 19 |
| 2005 | 18 | 5 | 23 |
| 2006 | 25 | 3 | 28 |
| 2007 | 35 | 4 | 39 |
| 2008 | 38 | 4 | 42 |
| 2009 | 30 | 8 | 38 |
| 2010 | 48 | 7 | 55 |
| 2011 | 45 | 5 | 50 |
| 2012 | 38 | 3 | 41 |
| 2013 | 29 | 6 | 35 |
| 2014 | 30 | 3 | 33 |
| 2015 | 35 | 6 | 41 |
| 2016 | 34 | 3 | 37 |
| 2017 | 42 | 6 | 48 |
| 2018 | 32 | 5 | 37 |
| 2019 | 39 | 3 | 42 |
| 2020 | 33 | 4 | 37 |
| 2021 | 38 | 1 | 39 |
| 2022 | 54 | 2 | 56 |
| 2023 | 36 | 0 | 36 |
| 2024 | 35 | 7 | 42 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glioma" by people in Profiles.
-
Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. Neuro Oncol. 2024 Dec 09; 26(Supplement_9):S208-S214.
-
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. Neuro Oncol. 2024 Dec 05; 26(12):2239-2255.
-
Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas. Viruses. 2024 Nov 14; 16(11).
-
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas. Neuro Oncol. 2024 Nov 04; 26(11):2044-2060.
-
Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables. Lab Invest. 2024 Dec; 104(12):102160.
-
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Neuro Oncol. 2024 Oct 03; 26(10):1805-1822.
-
A brave new framework for glioma drug development. Lancet Oncol. 2024 Oct; 25(10):e512-e519.
-
EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner. Stem Cell Reports. 2024 10 08; 19(10):1516.
-
Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium. AJNR Am J Neuroradiol. 2024 Sep 09; 45(9):1299-1307.
-
Integrated electrophysiological and genomic profiles of single cells reveal spiking tumor cells in human glioma. Cancer Cell. 2024 Oct 14; 42(10):1713-1728.e6.